Market News How it works Learn FAQ
| GPUS 0.1689 34.05% | XXII 0.1977 -8.34% | SHFS 0.1324 -61.39% | NVD 4.19 0.96% | LUCD 0.411 25.42% | SPCX 147.49 1.89% | T 20.93 -7.96% | SOXL 83.56 1.77% | NU 15.16 2.92% | NOK 8.14 3.30% | EWZ 42.59 1.77% | NVDA 210.96 -0.59% | RIME 0.106 -12.90% | INTC 86.96 1.72% | TSLG 4.87 -1.62% | AAL 12.11 -3.89% | BBD 4.07 3.04% | STLA 4.06 -4.81% | SOXS 52.46 -1.85% | RWM 14.55 0.34% | HYG 77.05 -0.06% | MYND 0.24 47.42% | BITO 10.83 -0.28% | SPDN 8.54 0.47% | YFOR 0.2236 -1.58% | RBNE 0.19 -2.56% | TQQQ 66.29 -0.20% | VZ 44.66 -1.19% | TSLL 9.76 -1.21% | SPTI 27.63 -0.11% | YMAT 2.05 6.77% | CRWV 54.235 -2.46% | INFY 12.35 -6.58% | RIG 6.41 5.43% | F 11.6 -2.85% | SQQQ 39.68 0.20% | AIOK 12.02 182.82% | ONDS 6.2 2.99% | AAPL 347.725 -0.14% | LABT 0.31 -36.67% | CDE 13.45 -3.10% | PCG 12.63 -2.70% | GRAB 2.79 -2.11% | SOFI 14.615 -1.05% | XLE 69.33 2.60% | IREN 24.905 -2.37% | QID 14.55 0.14% | RKT 11.73 -0.09% | WULF 11.32 0.00% | BE 193.3 -11.24%
QUuniQure N.V. logo

uniQure N.V. (QURE)

NASDAQ · Currency in USD
$22.43 ▼ -0.68 (-2.94%)
At close: Oct 23, 4:00 PM ET. Market closed.
$22.66 ▲ +0.23 (+1.03%)
After hours: Oct 23, 7:45 PM ET

Summary

Previous Close
$23.11
Open
$23.28
Day's Range
$22.04 – $23.28
52 Week Range
$8.73 – $71.50
Volume
883,649
Avg. Volume
2,229,138
Market Cap
$1.56B
Beta (5Y Monthly)
0.94
PE Ratio (TTM)
--
EPS (TTM)
-$3.81
Earnings Date
Nov 9, 2026
Forward Dividend & Yield
--
Ex-Dividend Date
--
1y Target Est
$52.18

Profile: uniQure N.V.

Sector
Healthcare
Industry
Biotechnology
Full-time employees
221
CEO
Matthew C. Kapusta

uniQure N.V. develops treatments for patients suffering from rare and other devastating diseases in the United States. The company offers HEMGENIX that allows people living with hemophilia B to produce factor IX, which can lower the risk of bleeding. Its lead product candidate is AMT-130, a gene therapy candidate, which is in phase I/II clinical study for the treatment of Huntington’s disease.

Earnings

Next report: Mon, Nov 9, 2026
EPS estimate -$0.92 · Revenue est. $6.17M
DateEst.Actual
Jul 29, 2026-$0.82-$1.22Miss
May 5, 2026-$0.88-$0.85Beat
Mar 2, 2026-$0.93-$0.56Beat
Nov 10, 2025-$0.85-$1.38Miss
Jul 29, 2025-$0.89-$0.69Beat
May 9, 2025-$1.07-$0.82Beat

Analyst view

Consensus price target
$52.18 ▲ +132.6%
Range $28.00 – $80.00
Rating: Buy
Buy 84% · Hold 16% · Sell 0%

Get free alerts on QURE and big market moves

Free special alerts by text & email on new investment opportunities, buyouts and the stocks moving most, in plain English.
Get free stock alerts →
Data: Financial Modeling Prep. For information only, not investment advice.